-transparent.png){kind=logo}
Between 1986 and 1989, 14 patients undergoing cystectomy for bladder cancer, in pathological stage high risk pT2 group, pT3-4 and/or with N+ disease, received postoperative adjuvant methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy. Of the 14 patients 10 were alive with no evidence of disease for an average of 41 months. Tumor recurrence was seen in 4 patients (bone in 2, lungs in 1, brain in 1 patient). Of the 4 patients, 3 patients died of cancer progression at an average of 26 months and 1 patient was alive with tumor for 30 months. Their actual survival rate at 64 months was 70%, which was significantly higher than that of the historical control groups (1974-1981: 18%, 1982-1985: 46%). Although postoperative adjuvant M-VAC chemotherapy for invasive bladder cancer seemed effective in this study, a controlled randomized study will be necessary to conclude if it could be of real benefit for these patients.
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
September 1989,
British journal of urology,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
April 1992,
Hinyokika kiyo. Acta urologica Japonica,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
June 1995,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
January 1990,
Archivos espanoles de urologia,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
January 1987,
Cancer chemotherapy and pharmacology,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
August 2001,
Seminars in urologic oncology,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
January 1987,
Cancer chemotherapy and pharmacology,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
January 1994,
Cancer chemotherapy and pharmacology,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
October 1990,
Seminars in oncology,
S Yamashita, and
K Taniguchi, and
H Morimitsu, and
H Suzu, and
H Kanetake, and
Y Saito, and
Y Yushita, and
T Sakuragi
December 1995,
Seminars in oncology,
